» Authors » Kevin S Harrod

Kevin S Harrod

Explore the profile of Kevin S Harrod including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 73
Citations 1516
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Li Q, Vijaykumar K, Phillips S, Hussain S, Huynh N, Fernandez-Petty C, et al.
JCI Insight . 2023 Jan; 8(1). PMID: 36625345
Substantial clinical evidence supports the notion that ciliary function in the airways is important in COVID-19 pathogenesis. Although ciliary damage has been observed in both in vitro and in vivo...
12.
Schultz M, Suschak J, Botta D, Silva-Sanchez A, King R, Detchemendy T, et al.
Hum Vaccin Immunother . 2022 Oct; 18(6):2127292. PMID: 36194255
The coronavirus disease 2019 (COVID-19) pandemic has illustrated the critical need for effective prophylactic vaccination to prevent the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Intranasal vaccination is...
13.
Li Q, Vijaykumar K, Philips S, Hussain S, Huynh V, Fernandez-Petty C, et al.
bioRxiv . 2022 Jan; PMID: 35075457
Substantial clinical evidence supports the notion that ciliary function in the airways plays an important role in COVID-19 pathogenesis. Although ciliary damage has been observed in both and models, consequent...
14.
Goliwas K, Wood A, Simmons C, Khan R, Khan S, Wang Y, et al.
medRxiv . 2021 Sep; PMID: 34518842
Multi-specific and long-lasting T cell immunity have been recognized as indicators for long term protection against pathogens including the novel coronavirus SARS-CoV-2, the causative agent of the COVID-19 pandemic. Functional...
15.
King R, Silva-Sanchez A, Peel J, Botta D, Dickson A, Pinto A, et al.
Vaccines (Basel) . 2021 Aug; 9(8). PMID: 34452006
The coronavirus disease 2019 (COVID-19) pandemic has highlighted the urgent need for effective prophylactic vaccination to prevent the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Intranasal vaccination is...
16.
Pacl H, Tipper J, Sevalkar R, Crouse A, Crowder C, Ahmad S, et al.
bioRxiv . 2021 Jul; PMID: 34282419
The recent emergence of a novel coronavirus, SARS-CoV-2, has led to the global pandemic of the severe disease COVID-19 in humans. While efforts to quickly identify effective antiviral therapies have...
17.
Langley R, Migaud M, Flores L, Thompson J, Kean E, Mostellar M, et al.
Sci Rep . 2021 May; 11(1):10515. PMID: 34006901
Acute respiratory failure (ARF) requiring mechanical ventilation, a complicating factor in sepsis and other disorders, is associated with high morbidity and mortality. Despite its severity and prevalence, treatment options are...
18.
Yepsen E, Harrod K
Am J Respir Cell Mol Biol . 2021 Apr; 65(1):1-3. PMID: 33848230
No abstract available.
19.
King R, Silva-Sanchez A, Peel J, Botta D, Meza-Perez S, Allie R, et al.
bioRxiv . 2020 Oct; PMID: 33052351
The coronavirus disease 2019 (COVID-19) pandemic has highlighted the urgent need for effective preventive vaccination to reduce burden and spread of severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) in...
20.
Gonzalez-Juarbe N, Riegler A, Jureka A, Gilley R, Brand J, Trombley J, et al.
Cell Rep . 2020 Aug; 32(8):108062. PMID: 32846120
Pneumonias caused by influenza A virus (IAV) co- and secondary bacterial infections are characterized by their severity and high mortality rate. Previously, we have shown that bacterial pore-forming toxin (PFT)-mediated...